Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials

Mise à jour : Il y a 4 ans
Référence : NCT00239356

Femme et Homme

Extrait

The purpose of this study is to provide aripiprazole to schizophrenic outpatients and Community Treated Patients who are currently receiving aripiprazole therapy on another BMS sponsored clinical trial.


Critère d'inclusion

  • Schizophrenia


Liens